(Q39323223)

11 September 2017

Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma (English)

1 reference

11 September 2017

0 references

mesenchymal stem cell

1 reference

H Kosaka

1

1 reference

11 September 2017

T Ichikawa

2

1 reference

11 September 2017

K Kurozumi

3

1 reference

11 September 2017

H Kambara

4

1 reference

11 September 2017

S Inoue

5

1 reference

11 September 2017

T Maruo

6

1 reference

11 September 2017

K Nakamura

7

1 reference

11 September 2017

H Hamada

8

1 reference

11 September 2017

I Date

9

1 reference

11 September 2017

29 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

19

1 reference

11 September 2017

8

1 reference

11 September 2017

572-578

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2012.35

11 September 2017

0 references

cites work

Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Stem cell research has only just begun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Glioma invasion in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Angiogenesis and invasion in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Growth control of C6 glioma in vivo by nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

inferred from DOI database lookup

7 January 2021

based on heuristic

Phase II Trials of Interferons-α and -β in Advanced Sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

inferred from DOI database lookup

7 January 2021

based on heuristic

Spontaneous human adult stem cell transformation.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2012.35

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2012.35

1 reference

11 September 2017

1 reference